CODX vs ZBRA · rev $3.9M vs P/E 28, rev $4.98B
Co-Diagnostics, Inc. Common Stock (CODX) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported ZBRA revenue for 2024-12-31 was $4.98B. Net income was $528.0M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
CODX currently screens at market cap $31.4M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the CODX and ZBRA stock pages for the full models.
Not investment advice.